Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-15 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 2 D011565 ClinicalTrials
Celiac Disease 2 D002446 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Vitiligo 2 D014820 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109467